Kyoto iCAP plans to determine a base in Taiwan by end-2026, a transfer that president Ko Kusumi describes as important. “As a springboard into Asia, Taiwan is extraordinarily promising,” he stated in an interview with JStories. “The time distinction is minimal, and in contrast with different markets, it’s far simpler to enter. Together with Singapore, it gives a pure gateway.”
Reflecting the strengths of Kyoto College’s analysis, life sciences firms make up about half of Kyoto iCAP’s portfolio; primarily based on funding worth, the share is even greater. So far, Kyoto iCAP has backed greater than 70 startups, of which lower than 10 % are abroad ventures.
A ‘small Silicon Valley’
The push abroad is matched by a strengthening startup ecosystem at house. On the middle of Kyoto sits KOIN, a co-working hub with practically 8,000 members and greater than 200 occasions a yr. “Out of the 600-plus startups in Kyoto Prefecture, I might say nearly all both purpose for abroad enlargement or are no less than keen on it,” stated Yuki Kanayama, deputy director of the group that manages KOIN.
Amongst them are a rising variety of pupil entrepreneurs. “Sensible pupil founders are rising one after one other from Kyoto,” Kanayama stated. Fields vary from inexperienced tech and AI to life sciences and {hardware}, creating an ecosystem some have known as a “small Silicon Valley” within the coronary heart of Japan.
Sport-changing applied sciences
‘World First’ methods, even transferring overseas
“Given the dimensions of funding and the scale of the market, relocating abroad is commonly the rational alternative,” Kusumi stated. The guiding philosophy: develop the science in Japan, however commercialize wherever the enterprise surroundings is most favorable.
Taiwan: stage for proof-of-concept
That logic is driving Kyoto’s growing curiosity in Taiwan as a proving floor. Scientific trials and pilot initiatives which are tough to conduct in Japan can typically be executed extra easily there. Kusumi remembers seeing autonomous driving assessments in Hong Kong 5 or 6 years in the past, powered — he later discovered — by a Kyoto College professor’s expertise.
“It was gratifying to see our analysis utilized in society,” he stated. “However on the identical time, it was irritating to appreciate that international startups had been those placing it to make use of earlier than Japan.”
The Information Capital Affiliation’s deputy director, Kanayama, agreed that Taiwan may ease that frustration. The island might be the best testing stage for Japanese biotech and drug discovery startups earlier than they go world, he stated.
A brand new cross-border innovation mannequin
The ambition goes past exporting Japanese expertise. Innovators in Kyoto and Taiwan hope to mix the strengths of Japan’s cutting-edge science with Taiwan’s and even Southeast Asia’s market alternatives. That’s as a result of many see Taiwan as a gateway for Japanese corporations to develop additional into Southeast Asian nations by way of the area’s community of Chinese language-speaking enterprise neighborhood.
Kyoto iCap already has a liaison workplace in Singapore. With a deliberate new workplace in Taipei, the college VC goals to realize traction all through East and Southeast Asia, an enormous market with a mixed inhabitants of two.3 billion folks.
“Worldwide enlargement will not be an finish in itself,” Kusumi stated. “It’s a way to realize the true purpose: bringing Japan’s analysis outcomes into society as rapidly as doable. If which means launching in Taiwan as an alternative of Japan, that’s high-quality. What issues is velocity.”
Prime photograph: Picture courtesy of Startup Island TAIWAN
For inquiries relating to this text, please contact [email protected]
